A2B adenosine receptor antagonists

Details A2B adenosine receptor antagonists A2B adenosine receptor antagonists

2005-12-20

2005-12-20

Berch, Mark L. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Chalcogen bonded directly to ring carbon of the purine ring...

C544S267000, C544S270000, C544S271000, C544S272000

Reexamination Certificate

active

06977300

ABSTRACT:
Disclosed are novel A2Badenosine receptor antagonists having the structure of Formula I or Formula II:The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.

REFERENCES:
patent: 4452788 (1984-06-01), Bristol et al.
patent: 4558051 (1985-12-01), Sunshine et al.
patent: 4593095 (1986-06-01), Snyder et al.
patent: 4879296 (1989-11-01), Daluge et al.
patent: 5532368 (1996-07-01), Kufner-Muhl et al.
patent: 5641784 (1997-06-01), Kufner-Muhl et al.
patent: 5714494 (1998-02-01), Connell et al.
patent: 5776940 (1998-07-01), Daluge et al.
patent: 6060481 (2000-05-01), LaNoue et al.
patent: 6117878 (2000-09-01), Linden
patent: 6437154 (2002-08-01), Chattopadhyay et al.
patent: 6545002 (2003-04-01), Linden et al.
patent: 6825349 (2004-11-01), Kalla et al.
patent: 0386683 (1990-09-01), None
patent: 0986855 (1998-04-01), None
patent: 1 084 710 (2001-03-01), None
patent: WO 95/11681 (1995-05-01), None
patent: WO 99/42092 (1999-08-01), None
patent: WO 00/09507 (2000-02-01), None
patent: WO 00/73307 (2000-12-01), None
Profire, Farmacia 1997 45(6) 55-68.
Mazur, Farmatsevtichnii Zh. 1996 (3) 82-84.
Priimenko, Ukrainskii Khimicheskii Zh. 62(7-8) 121-24.
Klosa, Arch. Pharm. 1956 289, 211-217.
Kuz' Menko II et al, “Reactions of Theophyllines, Chemical Conversions of 8-Aminotheophyllinates” Chemistry of Heterocyclic Compounds (A translation of Khimiya Geterotsiklicheskikh Soedinernii), Plenum Press Co., New york NY, US, vol. 36, No. 8, 2000 pp. 963-970 XP001146936 ISSN: 0009-3122 examples 3K, 3L,8.
Jacobson K A et al: “1,3-Dialkylxanthine derivatives having high potency as antagonists at human A2B adenosine receptors”, Drug Development Research, New York, NY, US, vol. 47, No. 1, 1999, pp. 45-53, XP000942540, abstract, example 10D.

Affiliated with

Also associated with

Rating

A2B adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A2B adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A2B adenosine receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3472709